Semaglutide reduces HbA(1c) and body weight across baseline HbA(1c) subgroups in the SUSTAIN 1-5 clinical trials

Bain, S; Araki, E; Desouza, C; Garg, S; Rose, L; Tsoukas, G; Bergan, E; Karsbol, JD; DeVries, J

DIABETOLOGIA, 2017; 60 ( ): S375